Related Experiment Videos

The protein C pathway

C Esmon1

  • 1Oklahoma Medical Research Foundation, Oklahoma City 73104, USA. charles-esmon@omrf.ouhsc.edu

Critical Care Medicine
|September 28, 2000
PubMed
Abstract

Insights

The protein C anticoagulant pathway is vital for controlling microvascular thrombosis. Protein C deficiency in sepsis worsens inflammation and endothelial dysfunction, but supplementation may offer therapeutic benefits.

Area of Science:

  • Biochemistry
  • Hematology
  • Immunology

Background:

  • The protein C system is a critical regulator of blood coagulation.
  • Inflammation can impair protein C anticoagulant function.
  • The protein C pathway also possesses anti-inflammatory properties.

Purpose of the Study:

  • To investigate the role of the protein C anticoagulant pathway in microvascular thrombosis.
  • To review how inflammation affects protein C pathway function.
  • To explore how the protein C pathway modulates inflammation.

Main Methods:

  • Literature review of primary research.
  • Inclusion of studies on the protein C pathway and inflammation.
  • Summary of clinical experience with protein C therapy in sepsis.

Main Results:

  • The protein C anticoagulant pathway is essential for regulating microvascular thrombosis.
  • Protein C deficiency in sepsis promotes thrombin generation and inflammation.
  • Preliminary data suggest protein C/activated protein C may improve microvascular function.

Conclusions:

  • The protein C system plays a key role in preventing microvascular thrombosis.
  • Dysfunction of the protein C pathway in sepsis contributes to thrombosis and inflammation.
  • Protein C supplementation shows potential for treating sepsis-induced microvascular dysfunction.

Related Concept Videos